Investing.com - Stifel downgraded Alcon Inc. (NYSE:ALC) from Buy to Hold and lowered its price target to $80.00 from $85.00 on Friday. The new target aligns closely with Alcon’s current trading price ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company ...

Jan 6 (Reuters) - STAAR Surgical (STAA.O), opens new tab said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon (ALCC.S), opens new tab after failing to secure ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA) announced ...

Shareholders of Staar Surgical rejected a proposal to sell the company to Alcon for about $1.6 billion, a win for activist investors who had campaigned to block the deal Staar, a maker of implantable ...

Also check out Warehouse Liquidation FINAL Sale! 50% OFF! on the Johns Creek Patch calendar ...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...